Investments
68Portfolio Exits
9Funds
2Partners & Customers
1About Workday Ventures
Workday Ventures works with promising, early-stage companies to fuel the next generation of enterprise applications. It focuses on companies that apply data science and machine learning principles in the areas of analytics, applications, security, and platform technologies. The company is based in Pleasanton, California.
Latest Workday Ventures News
Oct 10, 2023
PALO ALTO, Calif.--(BUSINESS WIRE)--SkyHive®, a generative AI software company and a Workday (NASDAQ: WDAY) Ventures partner helping companies and communities around the world move from jobs-based to skills-based, today announced that it has achieved a Workday Certified Integration with Workday Human Capital Management (HCM). Joint Workday and SkyHive customers using Workday HCM and Workday Skills Cloud can manage their job catalogs and job architectures in Workday with labor market benchmarkin
Workday Ventures Investments
68 Investments
Workday Ventures has made 68 investments. Their latest investment was in Sana Labs as part of their Series B - II on May 5, 2023.
Workday Ventures Investments Activity
Date | Round | Company | Amount | New? | Co-Investors | Sources |
|---|---|---|---|---|---|---|
5/31/2023 | Series B - II | Sana Labs | $28M | Yes | 6 | |
5/10/2023 | Series B - IV | Vanta | Yes | 2 | ||
3/14/2023 | Series B | Adept | $350M | Yes | A.Capital, Addition, Atlassian Ventures, Caterina Fake, Frontiers Capital, General Catalyst, Greylock Partners, Microsoft, NVIDIA, PSP Growth, Spark Capital, SV Angel, Undisclosed Investors, and Yes VC | 12 |
11/14/2022 | Seed VC - III | |||||
10/13/2022 | Series B |
Date | 5/31/2023 | 5/10/2023 | 3/14/2023 | 11/14/2022 | 10/13/2022 |
|---|---|---|---|---|---|
Round | Series B - II | Series B - IV | Series B | Seed VC - III | Series B |
Company | Sana Labs | Vanta | Adept | ||
Amount | $28M | $350M | |||
New? | Yes | Yes | Yes | ||
Co-Investors | A.Capital, Addition, Atlassian Ventures, Caterina Fake, Frontiers Capital, General Catalyst, Greylock Partners, Microsoft, NVIDIA, PSP Growth, Spark Capital, SV Angel, Undisclosed Investors, and Yes VC | ||||
Sources | 6 | 2 | 12 |
Workday Ventures Portfolio Exits
9 Portfolio Exits
Workday Ventures has 9 portfolio exits. Their latest portfolio exit was Utmost on October 19, 2022.
Workday Ventures Acquisitions
1 Acquisition
Workday Ventures acquired 1 company. Their latest acquisition was Jobcase on July 09, 2020.
Date | Investment Stage | Companies | Valuation Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model. | Total Funding | Note | Sources |
|---|---|---|---|---|---|---|
7/9/2020 | Series B | $118.5M | Acq - Fin | 2 |
Date | 7/9/2020 |
|---|---|
Investment Stage | Series B |
Companies | |
Valuation | |
Total Funding | $118.5M |
Note | Acq - Fin |
Sources | 2 |
Workday Ventures Fund History
2 Fund Histories
Workday Ventures has 2 funds, including Workday Ventures II.
Closing Date | Fund | Fund Type | Status | Amount | Sources |
|---|---|---|---|---|---|
2/7/2023 | Workday Ventures II | $500M | 4 | ||
7/14/2015 | Workday Ventures I |
Closing Date | 2/7/2023 | 7/14/2015 |
|---|---|---|
Fund | Workday Ventures II | Workday Ventures I |
Fund Type | ||
Status | ||
Amount | $500M | |
Sources | 4 |
Workday Ventures Partners & Customers
1 Partners and customers
Workday Ventures has 1 strategic partners and customers. Workday Ventures recently partnered with Pipeline Equity on February 2, 2022.
Date | Type | Business Partner | Country | News Snippet | Sources |
|---|---|---|---|---|---|
2/23/2022 | Partner | United States | 1 |
Date | 2/23/2022 |
|---|---|
Type | Partner |
Business Partner | |
Country | United States |
News Snippet | |
Sources | 1 |
Workday Ventures Team
2 Team Members
Workday Ventures has 2 team members, including current Senior Vice President, Managing Director, Barbry McGann.
Name | Work History | Title | Status |
|---|---|---|---|
Barbry McGann | Senior Vice President, Managing Director | Current | |
Loading...